Fisher Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $20M | Sell |
|
|||||
|
2025
Q2 | $24.9M | Sell |
|
|||||
|
2025
Q1 | $22.9M | Sell |
|
|||||
|
2024
Q4 | $23.9M | Sell |
|
|||||
|
2024
Q3 | $25.4M | Buy |
|
|||||
|
2024
Q2 | $17.7M | Sell |
|
|||||
|
2024
Q1 | $14.7M | Buy |
|
|||||
|
2023
Q4 | $17.3M | Sell |
|
|||||
|
2023
Q3 | $22.6M | Sell |
|
|||||
|
2023
Q2 | $30.4M | Buy |
|
|||||
|
2023
Q1 | $35.8M | Sell |
|
|||||
|
2022
Q4 | $50.9M | Sell |
|
|||||
|
2022
Q3 | $65.1M | Sell |
|
|||||
|
2022
Q2 | $55.2M | Buy |
|
|||||
|
2022
Q1 | $64.8M | Sell |
|
|||||
|
2021
Q4 | $56.7M | Buy |
|
|||||
|
2021
Q3 | $43.2M | Buy |
|
|||||
|
2021
Q2 | $31.8M | Buy |
|